INCR
INCR
NASDAQ · Pharmaceuticals

Intercure Ltd

$3.61
-0.41 (-10.20%)
As of Nov 7, 2:23 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,006.6% upside
Low Target $34.56
Average Target $39.95
High Target $63.39
Current Price $3.61
Current
$3.61
Target
$39.95
$34.56 $39.95 avg $63.39
Scenario Analysis
Bear Case
$34.56
857.3%
Low target
Base Case
$39.95
+1,006.6%
Avg target
Bull Case
$63.39
+1,656.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2,423.50
-99.9% from high
52-Week Low
$253.30
+-98.6% from low
Target vs 52W High
$39.95
-98.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%